HomeTOP STORIESAbbVie in charts: Revenues from Humira -49%, Skyrizi +57.8%, Rinvoq +46% Y/Y AbbVie in charts: Revenues from Humira -49%, Skyrizi +57.8%, Rinvoq +46% Y/Y By rogerjudd January 31, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleFirst BanCorp. appoints for new post of chief consumer officer as part of reorganizationNext articleJapanese Chin: Training, Care, and Emotional Support latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
